HomeAnswersPulmonology (Asthma Doctors)mycobacterial infections

How can my 66-year-old wife manage her MAC?

This Premium Q&A, reviewed and published, features a real conversation between an iCliniq user and a physician.

Patient's Query

Hi doctor,

My 66-year-old wife was diagnosed with Mycobacterium avium complex (MAC) lung disease eight months ago after having a chronic cough for over two years.

Her CT scan shows bronchiectasis and multiple nodules throughout both lungs, especially in the right middle lobe. The sputum cultures grew MAC three separate times, confirming the diagnosis. Her pulmonologist started her on Azithromycin, Ethambutol, and Rifampin daily, but she has been experiencing terrible side effects. The Rifampin turned her urine orange, which frightened her, and Ethambutol is affecting her vision, causing color blindness.

She has lost 18 pounds because the medications make her nauseous and suppress her appetite. The MAC lung disease causes a daily cough with thick mucus production and night sweats that soak through her pajamas. She also has such severe fatigue that she can barely perform simple household tasks.

She has been on treatment for eight months, but repeat cultures are still showing MAC bacteria. Her doctor says treatment needs to continue for 12 months after negative cultures, which seems like forever. Are there alternative medications for MAC lung disease? What happens if the bacteria never clear?

Please suggest.

Answered by Dr. Amandeep Singh Arneja

Education:

MD RESPIRATORY MEDICINE

Professional Bio:

I am Dr. Amandeep Singh Arneja, a dedicated Chest Physician and Senior Resident in Pulmonary Medicine at Jawaharlal Nehru Medical College (JNMC), Wardha, with extensive training in the management of complex respiratory and critical care conditions. I completed my M.B.B.S. from Universal College of Medical Sciences, Tribhuvan University (2016) and M.D. in Respiratory Medicine from Shri Shankaracharya Institute of Medical Sciences, Bhilai (2025), where I gained hands-on expertise in managing ICU patients, performing advanced diagnostic and therapeutic procedures, and conducting research in pulmonary diseases. My areas of expertise include: Management of asthma, COPD, tuberculosis, and interstitial lung disease Critical care management (ICU care, mechanical ventilation) Pulmonary function testing (spirometry, DLCO) Interventional procedures (thoracentesis, ICD insertion, bronchoscopy) Sleep medicine and polysomnography Research, academic writing, and clinical presentations I hold certifications in Good Clinical Practice and Biomedical Research. I am a proud member of the National College of Chest Physicians (NCCP). Alongside my pulmonary expertise, I have also completed a CPCDM Fellowship in Diabetes from RSSDI, enabling me to provide holistic care for patients with respiratory diseases complicated by diabetes. Currently, I am also pursuing a Fellowship in Critical Care Medicine, which further enhances my ability to manage critically ill patients with respiratory and systemic illnesses. With multiple research publications, conference presentations (NAPCON, SSIMSCON), and a strong academic background, I strive to combine evidence-based medicine with compassionate patient care. My mission is to provide comprehensive, high-quality care to patients suffering from respiratory and lifestyle-related diseases.

This doctor is not available for online consultations on the platform anymore.

Hi,

Welcome to icliniq.com.

I understand your concern.

From what you have described about Mycobacterium avium complex (MAC) lung disease, your wife is on the standard treatment.

The goal is to achieve three consecutive monthly negative cultures and then continue therapy for 12 months from the first negative culture. If cultures remain positive after eight months, we reassess two things in parallel: (1) drug side effects and dosing schedule and (2) reasons for microbiologic failure, including antibiotic resistance, inadequate drug exposure, and poor airway clearance.

First, regarding the side effects: orange urine and tears with Rifampin are expected and harmless, but nausea and appetite loss are real and can often be reduced. Many patients do better taking Rifampin and Azithromycin at bedtime, using an anti-nausea plan (Ondansetron 30 to 60 minutes before medications, with a small snack if needed).

If Ethambutol is causing color-vision changes, pause it immediately and get an urgent ophthalmology exam; this side effect is reversible if caught early. When Ethambutol must be stopped, alternatives such as Clofazimine can be substituted.

Second, the regimen and dosing can be adjusted to improve both tolerability and effectiveness. Thrice-weekly dosing can sometimes be easier on the stomach; however, if cultures remain positive, daily therapy or intensification is preferred. I would also send a fresh sputum sample for full susceptibility testing, explicitly confirming macrolide sensitivity.

If the MAC strain is still macrolide-susceptible but not converting, adding inhaled Amikacin liposome suspension is the next logical step. If ALIS (Amikacin liposome inhalation suspension) is not available, other substitute drugs can be discussed with her physician.

Airway clearance is as important as antibiotics. Daily chest physiotherapy with an oscillatory PEP (positive expiratory pressure) device, nebulized hypertonic saline, adequate hydration, and, when appropriate, a bronchodilator before clearance can reduce mucus load and bacterial burden.

It is also essential to treat co-factors that perpetuate infection, such as reflux, sinus issues, or low body weight. A nutrition plan with high-calorie, high-protein intake (or supplements) and proactive anti-nausea measures can help reverse the 18-pound weight loss; maintaining or regaining weight itself improves outcomes in MAC.

I hope this has helped you.

Please feel free to reach out to me again for further queries.

Thank you.

Medically reviewed by iCliniq medical review team
Published At December 24, 2025
Reviewed At December 29, 2025

Education:

MD RESPIRATORY MEDICINE

Professional Bio:

I am Dr. Amandeep Singh Arneja, a dedicated Chest Physician and Senior Resident in Pulmonary Medicine at Jawaharlal Nehru Medical College (JNMC), Wardha, with extensive training in the management of complex respiratory and critical care conditions. I completed my M.B.B.S. from Universal College of Medical Sciences, Tribhuvan University (2016) and M.D. in Respiratory Medicine from Shri Shankaracharya Institute of Medical Sciences, Bhilai (2025), where I gained hands-on expertise in managing ICU patients, performing advanced diagnostic and therapeutic procedures, and conducting research in pulmonary diseases. My areas of expertise include: Management of asthma, COPD, tuberculosis, and interstitial lung disease Critical care management (ICU care, mechanical ventilation) Pulmonary function testing (spirometry, DLCO) Interventional procedures (thoracentesis, ICD insertion, bronchoscopy) Sleep medicine and polysomnography Research, academic writing, and clinical presentations I hold certifications in Good Clinical Practice and Biomedical Research. I am a proud member of the National College of Chest Physicians (NCCP). Alongside my pulmonary expertise, I have also completed a CPCDM Fellowship in Diabetes from RSSDI, enabling me to provide holistic care for patients with respiratory diseases complicated by diabetes. Currently, I am also pursuing a Fellowship in Critical Care Medicine, which further enhances my ability to manage critically ill patients with respiratory and systemic illnesses. With multiple research publications, conference presentations (NAPCON, SSIMSCON), and a strong academic background, I strive to combine evidence-based medicine with compassionate patient care. My mission is to provide comprehensive, high-quality care to patients suffering from respiratory and lifestyle-related diseases.

This doctor is not available for online consultations on the platform anymore.

Same symptoms don't mean you have the same problem. Consult a doctor now!

2,876Checks completed today
4.8/5User rating
~2 minAverage completion time
Evidence-basedGuideline aligned
Decision Helper
MAC Lung Disease Management Decision Helper

Is your MAC lung disease treatment on track?

Answer five quick questions to understand if your current Mycobacterium avium complex (MAC) lung disease management needs adjustment or further discussion with your doctor.

This tool provides educational information only and does not diagnose, treat, or replace professional medical advice. Consult a qualified healthcare professional for personalized medical guidance.

Education:

MD RESPIRATORY MEDICINE

Professional Bio:

I am Dr. Amandeep Singh Arneja, a dedicated Chest Physician and Senior Resident in Pulmonary Medicine at Jawaharlal Nehru Medical College (JNMC), Wardha, with extensive training in the management of complex respiratory and critical care conditions. I completed my M.B.B.S. from Universal College of Medical Sciences, Tribhuvan University (2016) and M.D. in Respiratory Medicine from Shri Shankaracharya Institute of Medical Sciences, Bhilai (2025), where I gained hands-on expertise in managing ICU patients, performing advanced diagnostic and therapeutic procedures, and conducting research in pulmonary diseases. My areas of expertise include: Management of asthma, COPD, tuberculosis, and interstitial lung disease Critical care management (ICU care, mechanical ventilation) Pulmonary function testing (spirometry, DLCO) Interventional procedures (thoracentesis, ICD insertion, bronchoscopy) Sleep medicine and polysomnography Research, academic writing, and clinical presentations I hold certifications in Good Clinical Practice and Biomedical Research. I am a proud member of the National College of Chest Physicians (NCCP). Alongside my pulmonary expertise, I have also completed a CPCDM Fellowship in Diabetes from RSSDI, enabling me to provide holistic care for patients with respiratory diseases complicated by diabetes. Currently, I am also pursuing a Fellowship in Critical Care Medicine, which further enhances my ability to manage critically ill patients with respiratory and systemic illnesses. With multiple research publications, conference presentations (NAPCON, SSIMSCON), and a strong academic background, I strive to combine evidence-based medicine with compassionate patient care. My mission is to provide comprehensive, high-quality care to patients suffering from respiratory and lifestyle-related diseases.

This doctor is not available for online consultations on the platform anymore.

Listen to related tracks in our music library
Comprehensive Second Opinion

Ask your health query to a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.